{"name":"Hopewell Therapeutics, Inc","round":{"amountQuarantined":false,"amountUsd":500000,"connectionsAmong":[],"currency":"USD","date":"2020-12-07","investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656220000001/primary_doc.xml"},"name":"Qiaobing Xu","role":"director","roleAsStated":"Director","slug":"qiaobing-xu"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656220000001/primary_doc.xml"},"name":"Qiaobing Xu","role":"executive","roleAsStated":"Executive Officer","slug":"qiaobing-xu"}],"slug":"hopewell-tx-com-2020-12-07-round-0001836562-20-000001","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-28","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656220000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1836562/000183656220000001/primary_doc.xml"},"slug":"hopewell-tx-com"}